机构风向标 | 艾德生物(300685)2025年二季度已披露前十大机构持股比例合计下跌4.47个百分点

Core Insights - Aied Bio (300685.SZ) reported its semi-annual results for 2025, revealing that as of July 28, 2025, 15 institutional investors held a total of 175 million shares, representing 44.69% of the company's total equity [1] - The top ten institutional investors collectively held 44.59% of Aied Bio's shares, with a decrease of 4.47 percentage points compared to the previous quarter [1] Institutional Holdings - Four public funds increased their holdings this period, including 工银专精特新混合A, 汇丰晋信珠三角混合, 中金中证500A, and 富国医疗产业混合发起式A, with a slight increase in the proportion of shares held [2] - Two new public funds disclosed their holdings this quarter, namely 华宝中证医疗ETF and 招商核心优选A [2] - Thirteen public funds did not disclose their holdings this quarter, including 华安聚优精选混合 and 汇添富价值精选混合 [2] Social Security and Foreign Investment - One social security fund, 全国社保基金四一三组合, reduced its holdings by 1.45% compared to the previous quarter [2] - One foreign fund, 香港中央结算有限公司, also decreased its holdings by 0.90% [2]